FDA
-
-
-
-
-
-
-
Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at UChicago Medicine
-
-
-
-
-
-
-
Eledon reports Phase 2 kidney transplant trial results for tegoprubart
-
-
-
-
-
-
-
Eledon Pharmaceuticals Strengthens Leadership Team with Appointment of Eliezer Katz, M.D., FACS as Chief Medical Officer
-
-
-
-
-
-
-
Eledon Pharmaceuticals Reports Third Quarter 2022 Operating and Financial Results
-
-
-
-
-
-
-
Eledon Pharmaceuticals Reports Second Quarter 2022 Operating and Financial Results
-
-
-
-
-
-
-
Eledon Pharmaceuticals Announces Orphan Drug Designation Granted to Tegoprubart for the Prevention of Allograft Rejection in Pancreatic Islet Cell Transplantation
-
-
-
-
-
-
-
Eledon Pharmaceuticals Provides Corporate Update and 2022 Outlook
-
323,582 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

